Topical gel helps burn wounds heal faster using an existing FDA-approved drug

Researchers at the Terasaki Institute for Biomedical Innovation and the University of Arizona College of Medicine have developed a topical gel formulation with 4-aminopyridine (4-AP), to treat burn wounds, achieving near-complete closure in 21 days. The findings are published in the journal Biomaterials.

Continue Reading this article here